BVF Partners, Director: MoonLake Immunotherapeutics MLTX Sell · Filed 24/10/08

Trade details

Type: Insider sale
Amount: $51,529,450
Shares · price: 1,030,589 sh · $50.00 a share
Held after: 10,235,089 sh
Stock: MoonLake Immunotherapeutics MLTX
Person: BVF PartnersDirector
Trade date: 24/10/04
Filed: 24/10/08
Days to filing: 4 days

Sold 9.1% of holdings

Share of holding sold: 9.1%

MoonLake Immunotherapeutics trades, last 26 weeks

What else happened in MoonLake Immunotherapeutics around then

Filed or reported within 30 days of the trade day · 24/09/04~24/11/03

BVF Partners's recent trades

BVF PartnersDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$89.2M
837,914 sh
$89.2M
Filed 06/26
Traded 06/26
BVF PartnersDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$66.8M
627,597 sh
$66.8M
Filed 06/26
Traded 06/26
BVF PartnersDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$12.1M
113,289 sh
$12.1M
Filed 06/26
Traded 06/26
BVF PartnersDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$5.5M
51,858 sh
$5.5M
Filed 06/26
Traded 06/26
BVF PartnersSEE REMARKS and Footnotes
Planned saleKymera Therapeutics
Planned sale
Kymera Therapeutics
KYMR
$189.9M
1,630,658 sh
$189.9M
Filed 06/26
Traded 06/26

BVF Partners, Director — sold $51.5M of MoonLake Immunotherapeutics MLTX · 9.1% of holdings | Whalegun